Clal Biotechnology Industries Ltd

TA:CBI Israel Biotechnology
Market Cap
$11.56 Million
ILA4.31 Billion ILA
Market Cap Rank
#40409 Global
#363 in Israel
Share Price
ILA27.50
Change (1 day)
-5.17%
52-Week Range
ILA27.50 - ILA42.50
All Time High
ILA380.64
About

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to i… Read more

Clal Biotechnology Industries Ltd - Asset Resilience Ratio

Latest as of December 2024: 1.56%

Clal Biotechnology Industries Ltd (CBI) has an Asset Resilience Ratio of 1.56% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
ILA1.06 Million
Cash + Short-term Investments
Total Assets
ILA67.69 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2007–2024)

This chart shows how Clal Biotechnology Industries Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Clal Biotechnology Industries Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ILA0.00 0%
Short-term Investments ILA1.06 Million 1.56%
Total Liquid Assets ILA1.06 Million 1.56%

Asset Resilience Insights

  • Limited Liquidity: Clal Biotechnology Industries Ltd maintains only 1.56% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Clal Biotechnology Industries Ltd Industry Peers by Asset Resilience Ratio

Compare Clal Biotechnology Industries Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Clal Biotechnology Industries Ltd (2007–2024)

The table below shows the annual Asset Resilience Ratio data for Clal Biotechnology Industries Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 1.56% ILA1.06 Million ILA67.69 Million -3.25pp
2023-12-31 4.82% ILA7.63 Million ILA158.39 Million +1.84pp
2022-12-31 2.98% ILA5.44 Million ILA182.69 Million -16.29pp
2020-12-31 19.27% ILA118.34 Million ILA614.03 Million +6.80pp
2019-12-31 12.48% ILA76.98 Million ILA616.97 Million +6.24pp
2018-12-31 6.24% ILA63.40 Million ILA1.02 Billion +6.16pp
2017-12-31 0.08% ILA830.00K ILA1.03 Billion -0.40pp
2016-12-31 0.48% ILA5.39 Million ILA1.12 Billion -2.05pp
2015-12-31 2.53% ILA38.81 Million ILA1.53 Billion -10.97pp
2014-12-31 13.51% ILA227.94 Million ILA1.69 Billion +9.04pp
2013-12-31 4.47% ILA85.81 Million ILA1.92 Billion -1.25pp
2012-12-31 5.71% ILA99.93 Million ILA1.75 Billion -8.52pp
2011-12-31 14.23% ILA177.97 Million ILA1.25 Billion +5.54pp
2010-12-31 8.69% ILA118.56 Million ILA1.36 Billion -3.09pp
2009-12-31 11.78% ILA110.34 Million ILA936.32 Million +5.64pp
2008-12-31 6.15% ILA26.18 Million ILA425.92 Million +5.85pp
2007-12-31 0.29% ILA1.23 Million ILA420.47 Million --
pp = percentage points